Gene Editing Startup CRISPR Therapeutics Plots IPO

September 12, 2016 | The question remains whether CRISPR can do much better on the stock market than the other two publicly-traded gene editing companies, both of which are based in Cambridge and held IPOs earlier this year. Boston Business Journal